Literature DB >> 27432742

Kidney Transplantation Outcomes across GN Subtypes in the United States.

Michelle M O'Shaughnessy1, Sai Liu2, Maria E Montez-Rath2, Colin R Lenihan2, Richard A Lafayette2, Wolfgang C Winkelmayer3.   

Abstract

Differences in kidney transplantation outcomes across GN subtypes have rarely been studied. From the US Renal Data System, we identified all adult (≥18 years) first kidney transplant recipients (1996-2011) with ESRD attributed to one of six GN subtypes or two comparator kidney diseases. We computed hazard ratios (HRs) for death, all-cause allograft failure, and allograft failure excluding death as a cause (competing risks framework) using Cox proportional hazards regression. Among the 32,131 patients with GN studied, patients with IgA nephropathy (IgAN) had the lowest mortality rates and patients with IgAN or vasculitis had the lowest allograft failure rates. After adjusting for patient- and transplant-related factors, compared with IgAN (referent), FSGS, membranous nephropathy, membranoproliferative GN, lupus nephritis, and vasculitis associated with HRs (95% confidence intervals) for death of 1.57 (1.43 to 1.72), 1.52 (1.34 to 1.72), 1.76 (1.55 to 2.01), 1.82 (1.63 to 2.02), and 1.56 (1.34 to 1.81), respectively, and with HRs for allograft failure excluding death as a cause of 1.20 (1.12 to 1.28), 1.27 (1.14 to 1.41), 1.50 (1.36 to 1.66), 1.11 (1.02 to 1.20), and 0.94 (0.81 to 1.09), respectively. Considering external comparator groups, and comparing with IgAN, autosomal dominant polycystic kidney disease (ADPKD) and diabetic nephropathy associated with higher HRs for mortality [1.22 (1.12 to 1.34) and 2.57 (2.35 to 2.82), respectively], but ADPKD associated with a lower HR for allograft failure excluding death as a cause [0.85 (0.79 to 0.91)]. Reasons for differential outcomes by GN subtype and cause of ESRD should be examined in future research.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  chronic allograft failure; clinical epidemiology; glomerulonephritis; kidney transplantation; mortality

Mesh:

Year:  2016        PMID: 27432742      PMCID: PMC5280017          DOI: 10.1681/ASN.2016020126

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  41 in total

1.  Estimating the relative risk in cohort studies and clinical trials of common outcomes.

Authors:  Louise-Anne McNutt; Chuntao Wu; Xiaonan Xue; Jean Paul Hafner
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

2.  Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

Authors:  Herwig-Ulf Meier-Kriesche; Jesse D Schold; Titte R Srinivas; Bruce Kaplan
Journal:  Am J Transplant       Date:  2004-03       Impact factor: 8.086

3.  Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.

Authors:  Sanjeev Sethi; Mark Haas; Glen S Markowitz; Vivette D D'Agati; Helmut G Rennke; J Charles Jennette; Ingeborg M Bajema; Charles E Alpers; Anthony Chang; Lynn D Cornell; Fernando G Cosio; Agnes B Fogo; Richard J Glassock; Sundaram Hariharan; Neeraja Kambham; Donna J Lager; Nelson Leung; Michael Mengel; Karl A Nath; Ian S Roberts; Brad H Rovin; Surya V Seshan; Richard J H Smith; Patrick D Walker; Christopher G Winearls; Gerald B Appel; Mariam P Alexander; Daniel C Cattran; Carmen Avila Casado; H Terence Cook; An S De Vriese; Jai Radhakrishnan; Lorraine C Racusen; Pierre Ronco; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

4.  Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).

Authors:  S Hariharan; M B Adams; D C Brennan; C L Davis; M R First; C P Johnson; R Ouseph; V R Peddi; C J Pelz; A M Roza; F Vincenti; V George
Journal:  Transplantation       Date:  1999-09-15       Impact factor: 4.939

5.  Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

Authors:  J Bradley Layton; Susan L Hogan; Caroline E Jennette; Barbara Kenderes; Jenna Krisher; J Charles Jennette; William M McClellan
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

6.  Comorbid conditions in kidney transplantation: association with graft and patient survival.

Authors:  Christine Wu; Idris Evans; Raymond Joseph; Ron Shapiro; Henkie Tan; Amit Basu; Cynthia Smetanka; Ahktar Khan; Jerry McCauley; Mark Unruh
Journal:  J Am Soc Nephrol       Date:  2005-09-21       Impact factor: 10.121

7.  Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database.

Authors:  Suphamai Bunnapradist; Philip Chung; Alice Peng; Andy Hong; Peter Chung; Brian Lee; Sumina Fukami; Steven K Takemoto; Ajay K Singh
Journal:  Transplantation       Date:  2006-09-15       Impact factor: 4.939

8.  Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis.

Authors:  A V Mulay; C van Walraven; G A Knoll
Journal:  Am J Transplant       Date:  2009-04       Impact factor: 8.086

9.  The outcome of renal transplantation among systemic lupus erythematosus patients.

Authors:  Madhukar Chelamcharla; Basit Javaid; Bradley C Baird; Alexander S Goldfarb-Rumyantzev
Journal:  Nephrol Dial Transplant       Date:  2007-07-19       Impact factor: 5.992

10.  Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions.

Authors:  Sally R Hinchliffe; Paul C Lambert
Journal:  BMC Med Res Methodol       Date:  2013-02-06       Impact factor: 4.615

View more
  15 in total

1.  Chronological change of renal pathological findings in the proliferative glomerulonephritis with monoclonal IgG deposits considered to have recurred early after kidney transplantation.

Authors:  Takayuki Katsuno; Masashi Kato; Takashi Fujita; Naotake Tsuboi; Ryohei Hattori; Yasuhiko Ito; Shoichi Maruyama
Journal:  CEN Case Rep       Date:  2019-02-25

Review 2.  Kidney transplantation in ANCA-associated vasculitis.

Authors:  Michael S Sagmeister; Melissa Grigorescu; Ulf Schönermarck
Journal:  J Nephrol       Date:  2019-08-30       Impact factor: 3.902

3.  Post-Transplant Cardiovascular Disease.

Authors:  Kelly A Birdwell; Meyeon Park
Journal:  Clin J Am Soc Nephrol       Date:  2021-09-23       Impact factor: 8.237

4.  Recurrent Glomerular Disease after Kidney Transplantation: Diagnostic and Management Dilemmas.

Authors:  Audrey Uffing; Frank Hullekes; Leonardo V Riella; Jonathan J Hogan
Journal:  Clin J Am Soc Nephrol       Date:  2021-10-22       Impact factor: 8.237

5.  MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.

Authors:  Zhanmei Zhou; Jiao Wan; Xiaoyan Hou; Jian Geng; Xiao Li; Xiaoyan Bai
Journal:  Cell Death Dis       Date:  2017-03-09       Impact factor: 8.469

Review 6.  Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation.

Authors:  Gabriella Moroni; Mirco Belingheri; Giulia Frontini; Francesco Tamborini; Piergiorgio Messa
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

Review 7.  Recurrent and de novo Glomerulonephritis After Kidney Transplantation.

Authors:  Wai H Lim; Meena Shingde; Germaine Wong
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

8.  Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.

Authors:  Wen-Ling Yang; Bhadran Bose; Lei Zhang; Megan Mcstea; Yeoungjee Cho; Magid Fahim; Carmel M Hawley; Elaine M Pascoe; David W Johnson
Journal:  PLoS One       Date:  2019-08-23       Impact factor: 3.240

9.  A large, international study on post-transplant glomerular diseases: the TANGO project.

Authors:  Audrey Uffing; Maria José Pérez-Sáez; Gaetano La Manna; Giorgia Comai; Clara Fischman; Samira Farouk; Roberto Ceratti Manfro; Andrea Carla Bauer; Bruno Lichtenfels; Juliana B Mansur; Hélio Tedesco-Silva; Gianna M Kirsztajn; Anna Manonelles; Oriol Bestard; Miguel Carlos Riella; Silvia Regina Hokazono; Carlos Arias-Cabrales; Elias David-Neto; Carlucci Gualberto Ventura; Enver Akalin; Omar Mohammed; Eliyahu V Khankin; Kassem Safa; Paolo Malvezzi; Michelle Marie O'Shaughnessy; Xingxing S Cheng; Paolo Cravedi; Leonardo V Riella
Journal:  BMC Nephrol       Date:  2018-09-12       Impact factor: 2.388

10.  The Risk of Stroke in Kidney Transplant Recipients with End-Stage Kidney Disease.

Authors:  Shih-Ting Huang; Tung-Min Yu; Ya-Wen Chuang; Mu-Chi Chung; Chen-Yu Wang; Pin-Kuei Fu; Tai-Yuan Ke; Chi-Yuan Li; Cheng-Li Lin; Ming-Ju Wu; Chia-Hung Kao
Journal:  Int J Environ Res Public Health       Date:  2019-01-24       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.